>>> Bed Bath & Beyond misses by $0.28, misses on revs; comparable sales -2.6% y/

Bed Bath & Beyond misses by $0.28, misses on revs; comparable sales -2.6% y/y; lower FY18 EPS below consensus (shares halted) (27.03 -0.27)
  • Reports Q2 (Aug) earnings of $0.67 per share, $0.28 worse than the Capital IQ Consensus of $0.95; revenues fell 1.7% year/year to $2.94 bln vs the $3.01 bln Capital IQ Consensus.
    • Includes the unfavorable impacts of approximately $.08 per diluted share of cash restructuring charges associated with the acceleration of the realignment of our store management structure announced on August 3, 2017. The estimated costs associated with the impact of Hurricane Harvey of approximately $.02 per diluted share; and the impact of the new share-based payment accounting standard of approximately $.01 per diluted share.
  • Co issues downside guidance for FY18, sees EPS of $3.00 (prior: down LSD-10% from $4.58) vs. $4.00 Capital IQ Consensus Estimate.
    • The Co's planning assumptions reflect actual results through the fiscal second quarter and the continuation of the trends the Co has been experiencing, and the unfavorable impacts of: the cash restructuring charges associated with the acceleration of the realignment of our store management structure; Hurricanes Harvey and Irma; the adoption of the new shared based payment accounting standard; and further increases in its overall expense structure to reflect some of the accelerated spending associated with the Company's organizational changes and transformational initiatives. The Company is now modeling net earnings per diluted share for the full year to be about $3.00, with the balance of the net earnings per diluted share to be split approximately 20% in the fiscal third quarter and approximately 80% in the fiscal fourth quarter.